Trump's HIV funding cuts leave treatment steady but prevention and data reporting falter
TL;DR Summary
Official data show PEPFAR kept about 20 million people on HIV treatment in mid-2025, but prevention work deteriorated sharply: roughly 4 million fewer people were tested in Q4 2025, new treatment starts fell, PrEP enrollments dropped about 41%, and prevention programs for key populations collapsed to near zero, all amid workforce cuts and less transparent reporting—raising concerns of a hidden, long-term HIV surge despite seemingly steady treatment numbers.
- What really happened after Trump slashed HIV funding vox.com
- US is taking a ‘real risk’ with hasty shift in efforts to fight HIV, experts say The Guardian
- Two startlingly different views on long-awaited data on America's anti-HIV efforts NPR
- AIDS Relief Program Sees Drops in Testing and Diagnoses After Disruptions U.S. News & World Report
- What the Latest PEPFAR Data Reveal and Why It Matters avac.org
Reading Insights
Total Reads
1
Unique Readers
6
Time Saved
32 min
vs 33 min read
Condensed
99%
6,409 → 68 words
Want the full story? Read the original article
Read on vox.com